Memantine
Specifications
19982-08-2CAS Number
690-724-9EC Number
3,5-dimethyladamantan-1-amineIUPAC Name
C12H21NChemical Formula
179.3 g/molMolecular Weight
memantine; 19982-08-2; 3,5-dimethyladamantan-1-amine; 1-Amino-3,5-dimethyladamantane; Memantina; 3,5-Dimethyl-1-adamantanamine; Memantinum; 1,3-Dimethyl-5-adamantanamine; nemdatine; 3,5-Dimethyl-1-aminoadamantane; Tricyclo[3.3.1.13,7]decan-1-amine, 3,5-dimethyl-; DTXSID5045174; DRG-0267; 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine; W8O17SJF3T; D-145; NSC-757843; 1,3-Dimethyl-5-aminoadamantane; DTXCID3025174; CHEBI:64312; D 145; Tricyclo(3.3.1.13,7)decan-1-amine, 3,5-dimethyl-; Memantin; N06DX01; RefChem:5992; D145; 690-724-9; Axura; Memantine [INN]; Memantinum [INN-Latin]; Memantina [INN-Spanish]; 3,5-Dimethyl-1-adamantylamine; CHEMBL807; 3,5-dimethyladamantanylamine; Memantine (INN); alzantin; NCGC00015705-04; Memantine [INN:BAN]; CAS-19982-08-2; HSDB 7327; 3,5-dimethyltricyclo[3.3.1.1~3,7~]decan-1-amine; UNII-W8O17SJF3T; DMAA [Antiparkinson Agent]; MFCD02114015; DRG 0267; Exiba (TN); Spectrum_000607; MEMANTINE [MI]; MEMANTINE [HSDB]; Prestwick0_000978; Prestwick1_000978; Prestwick2_000978; Prestwick3_000978; Spectrum2_001408; Spectrum3_000923; Spectrum4_001022; Spectrum5_001355; MEMANTINE [VANDF]; CBMicro_020348; Biomol-NT_000209; MEMANTINE [WHO-DD]; SCHEMBL2688; Lopac0_000861; Oprea1_480562; BSPBio_001015; KBioGR_001543; KBioSS_001087; DivK1c_000068; SPBio_001456; SPBio_002926; 1-amino-3,5-dimethyladamantan; BPBio1_001117; BPBio1_001270; GTPL4253; orb1306483; SCHEMBL1938718; SCHEMBL7032803; HMS500D10; KBio1_000068; KBio2_001087; KBio2_003655; KBio2_006223; KBio3_001926; 1-amino-3,5-dimethyl adamantane; 1-amino-3,5-dimethyl-adamantane; Tricyclo(3.3.1.1(3,7))decan-1-amine, 3,5-dimethyl-; NINDS_000068; 3,5-Dimethyl-adamantan-1-ylamine; ALBB-013872; Tox21_110199; 3,5-Dimethyl-1-aminoadamantane HCl; BBL000737; BDBM50062599; EBC-26142; SBB002574; STK520682; AKOS000113995; AKOS015953276; AKOS016340748; Tox21_110199_1; CCG-204092; DB01043; DS-3152; NSC 757843; SDCCGSBI-0020417.P005; IDI1_000068; NCGC00015705-03; NCGC00015705-05; NCGC00015705-07; NCGC00015705-09; NCGC00015705-15; NCGC00015705-16; NCGC00024782-02; NCGC00024782-03; FM153268; ST057652; SBI-0020417.P004; AB00053600; EU-0053634; NS00000622; D08174; D94592; EN300-103626; T20993; AB00053600-13; AB00053600_14; AB00053600_15; Q412189; 3,5-dimethyl-Tricyclo[3.3.1.13,7]decan-1-amine; BRD-A79803969-003-16-1; BRD-A79803969-003-17-9; BRD-A79803969-003-18-7; 3,5-DIMETHYLTRICYCLO(3.3.1.1(SUP 3,7))DECAN-1-AMINE; TRICYCLO(3.3.1.1(SUP 3,7))DECAN-1-AMINE, 3,5-DIMETHYL-Synonyms
